Oscar Health, Inc. (NYSE:OSCR) Given Average Recommendation of “Reduce” by Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been given a consensus recommendation of “Reduce” by the five ratings firms that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $16.50.

A number of analysts recently issued reports on the stock. Wall Street Zen lowered shares of Oscar Health from a “buy” rating to a “hold” rating in a research note on Sunday. Piper Sandler dropped their price target on shares of Oscar Health from $25.00 to $18.00 and set an “overweight” rating for the company in a research note on Monday. Finally, Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th.

Oscar Health Stock Down 0.6%

Shares of NYSE:OSCR opened at $14.67 on Wednesday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a fifty day simple moving average of $13.93 and a 200 day simple moving average of $14.52. The firm has a market cap of $3.73 billion, a PE ratio of -732.88 and a beta of 1.73. Oscar Health has a 12-month low of $11.20 and a 12-month high of $23.79.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The business’s revenue was up 42.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.62 earnings per share. On average, equities research analysts anticipate that Oscar Health will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the transaction, the director now directly owns 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 24.39% of the stock is owned by insiders.

Hedge Funds Weigh In On Oscar Health

Institutional investors have recently modified their holdings of the company. Southeastern Asset Management Inc. TN grew its position in shares of Oscar Health by 52.2% during the fourth quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company’s stock worth $42,082,000 after acquiring an additional 1,073,359 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its position in shares of Oscar Health by 37.8% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company’s stock worth $23,403,000 after acquiring an additional 477,634 shares during the last quarter. Man Group plc grew its position in shares of Oscar Health by 344.8% during the fourth quarter. Man Group plc now owns 1,813,216 shares of the company’s stock worth $24,370,000 after acquiring an additional 1,405,554 shares during the last quarter. Toronto Dominion Bank bought a new position in shares of Oscar Health during the fourth quarter worth about $1,008,000. Finally, Lingotto Investment Management LLP bought a new position in shares of Oscar Health during the fourth quarter worth about $2,543,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.